New phase 3 trial results for XYZ Pharma's cancer drug
- XYZ Pharma announced positive results from its Phase 3 trial for its new cancer drug.
- The trial involved 500 patients across 20 countries.
- Results showed a significant improvement in overall survival rates.
- Next steps include filing for regulatory approval in the US and EU.
Read more
ABC Biotech and DEF Pharma enter strategic collaboration
- ABC Biotech and DEF Pharma have entered a strategic collaboration to develop new immunotherapies.
- The collaboration includes a $200 million upfront payment and potential milestone payments.
- The focus will be on developing treatments for rare cancers.
- Next steps involve initiating preclinical studies in early 2024.
Read more
FDA approves new indication for GHI Pharma's drug
- The FDA has approved a new indication for GHI Pharma's drug for treating metastatic breast cancer.
- Approval was based on data from a Phase 3 trial showing improved progression-free survival.
- Next steps include seeking approval in other major markets such as the EU and Japan.
Read more
